ALTERMUNE TECHNOLOGIES
Altermune Technologies LLC, a newly formed company focused on the development of novel therapeutics to combat resistant pathogens such as MRSA, C. difficile, pseudomonas, and pandemic influenza. The company is led by a team of in-house scientists, and a wide network of partnerships, including collaborative research arrangements with a number of universities in the USA and Europe and corporate relationships with companies in oligonucleotide synthesis and aptamer selection.
ALTERMUNE TECHNOLOGIES
Industry:
Biotechnology Therapeutics
Founded:
2010-01-01
Address:
Irvine, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
7 M USD
Current Employees Featured
Kary Banks Mullis
Kary Banks Mullis Founder & Chief Scientific Advisor @ Altermune Technologies Founder & Chief Scientific Advisor
Founder
Kary Banks Mullis
Investors List
Loxbridge Research
Loxbridge Research investment in Seed Round - Altermune Technologies